openPR Logo
Press release

Dermatophytic Onychomycosis Therapeutics Market Expanding due to Increasing Aging Population

Dermatophytic Onychomycosis Therapeutics Market Expanding

Dermatophytic onychomycosis, also known as tinea unguium, refers to a fungal infection of the nail. It accounts for more than half of the cases of nail diseases. Due to this disease, nails look thickened, white, opaque, and brittle. Individuals between 60-65 years of age and particularly those with conditions such as diabetes and peripheral vascular disease have increased chances of developing dermatophytic onychomycosis. In the general population, almost 10% of the population is affected by dermatophytic onychomycosis; the condition is usually manifested by severe pain that can impede everyday functioning.

The global dermatophytic onychomycosis therapeutics (DOT) market will expand at a CAGR of 7.50% from 2015 to 2021. Due to this, the market’s valuation of more than US$3 bn in 2015 will reach US$4.7 bn by 2021.

U.S., Canada Strong Contenders in Dermatophytic Onychomycosis Therapeutics Market

In the U.S. and Canada, the prevalence of fungal infections in toenails is on the rise, which is one of the major factors driving the DOT market. Thus, North America stands as the largest regional market for dermatophytic onychomycosis therapeutics and the region held a share of more than 43% in the global market in 2014. For the 2015-2021 period, North America will exhibit the highest CAGR of 9.20% in the global market for dermatophytic onychomycosis.

Across the globe, increased awareness, coupled with increased healthcare expenditure from both healthcare agencies and individuals, is also a significant factor driving this market. Rising per capita income, increasing inclination among consumers to maintain nail aesthetics, and consistent product innovations are significantly contributing to the market’s progression.

Interested in report: Please follow the below links to meet your requirements; Request for the Report Sample: http://www.persistencemarketresearch.com/samples/5840

However, anti-fungal drugs are associated with side effects, which is impeding the development of this market. In the under-developed regions of Asia Pacific, Latin America, and the Middle East and Africa, lack of education is another reason for the lack of awareness of the disease, which goes unnoticed many times. This is a reason restraining the development of the market as well.

View TOC (table of content), Figures and Tables of the Report: http://www.persistencemarketresearch.com/toc/5840

Nail Paint Dominates Product Segment of Global Market

The product segments of the dermatophytic onychomycosis therapeutics market are tablets and nail paints. Each segment is further sub-divided into over-the-counter and prescription products. Of the two product segments, it is the nail paint segment that will contribute a significant revenue to the global market; between 2015 and 2021 the nail paint product segment will expand at the faster CAGR of 8.30%.

On the basis of treatment, topical and oral therapy are the segments of this market. Between the two, the topical segment will be ahead and will account for almost 70% of the global market by 2021. By distribution channel, hospitals, independent pharmacies, drug stores, and mail order pharmacies are the segments of the global market for dermatophytic onychomycosis therapeutics. Of all, in 2014, drug stores contributed the highest revenue of US$1.3 bn, which represented a share of close to 47% in the global market. Independent pharmacies stood as the second largest distribution channel and accounted for almost 20% revenue of the market in 2014.

Key players that operate in the global market for dermatophytic onychomycosis therapeutics are Valeant Pharmaceuticals Inc., Novartis AG, Moberg Pharma AB, Anacor Pharmaceuticals Inc., Galderma S.A., Pfizer Inc., and Johnson & Johnson Services Inc.

About Us

Persistence Market Research (PMR) is a full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

Contact

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States
USA - Canada Toll Free: +1 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dermatophytic Onychomycosis Therapeutics Market Expanding due to Increasing Aging Population here

News-ID: 340686 • Views:

More Releases from Persistence Market Research

North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
Overview of the North America Wiring Devices Market The North America wiring devices market is poised for steady growth over the forecast period, with its size estimated at US$ 18.96 billion in 2024, projected to reach US$ 26.46 billion by 2031, reflecting a CAGR of 4.9%. The market is witnessing substantial expansion due to increasing urbanization, a rising number of residential and commercial construction projects, and the adoption of energy-efficient and
Global Forged Automotive Components Market Poised for Steady Growth, Projected to Reach US$ 70.7 Billion by 2032
Global Forged Automotive Components Market Poised for Steady Growth, Projected t …
The global forged automotive components market is on a robust growth trajectory, currently valued at approximately US$ 50.3 billion in 2025 and forecasted to expand to US$ 70.7 billion by the end of 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% over the coming decade, driven by increasing automotive production, technological advancements, and evolving consumer preferences toward durable, high-performance vehicle parts. Forged automotive components are critical to
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ 2.14 Billion by 2032, Reports Persistence Market Research
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ …
The global electric cargo bike market is set to experience substantial growth over the coming decade, with Persistence Market Research (PMR) forecasting a compound annual growth rate (CAGR) of 11.9% from 2023 through 2032. Valued at approximately US$ 800 million in 2021, the market is expected to surge to a projected valuation of US$ 2.14 billion by the end of 2032. Notably, electric cargo bikes accounted for 66.2% of the
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Driven by Urbanization and Demographic Trends
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Drive …
The global bicycle bearings market is poised for significant expansion over the forecast period of 2025 to 2032, according to the latest report released by Persistence Market Research. Valued at approximately US$ 5.99 billion in 2024, the market is projected to reach US$ 6.35 billion by 2025 and further escalate to nearly US$ 9.86 billion by 2032. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.5%, underscoring

All 5 Releases


More Releases for Dermatophytic

Call for Automation to Drive the Dermatophytic Onychomycosis Therapeutics Market
Advancements in medicine, diagnosis of varieties of illnesses, and increasing elder population at an unprecedented rate have resulted in high demand for novel drugs and therapies for dermatophytic onychomycosis treatment. In 2021, the dermatophytic onychomycosis therapeutics market was valued at nearly US$ 5.5 Bn, and is set to experience a 6.5% CAGR over the forecast period (2022-2031). Presence and availability of a large clinical pipeline with reference to therapeutic approaches based
Dermatophytic Onychomycosis Therapeutics (DOT) Market 2022 | Detailed Report
The research reports on “Dermatophytic Onychomycosis Therapeutics (DOT) Market” report gives detailed overview of factors that affect global business scope. Dermatophytic Onychomycosis Therapeutics (DOT) Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample
Dermatophytic Onychomycosis Therapeutics (DOT) Market
Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs. However, adverse effects associated with anti-fungal drugs and lack of awareness about dermatophytic onychomycosis in Asia Pacific, Middle East and Africa, and Latin
Dermatophytic Onychomycosis Market Expected to Witness a Sustainable Growth
According to a new report published by Allied Market Research, titled, " Dermatophytic Onychomycosis Market by Product (Nail Paint and Tablet), Route of Administration (Topical and Oral Therapy), and End User (Hospitals, Dermatology & Podiatry Clinics, Independent Pharmacies, Mail Order Pharmacies, and Drug Stores) - Global Opportunity Analysis and Industry Forecast, 2020-2027". The global market size of Dermatophytic Onychomycosis market is $XX million in 2019 with XX CAGR, and it is
Dermatophytic Onychomycosis Market Poised to Rake US$ 4,706.3 Mn by 2021
Key players of the global dermatophytic onychomycosis therapeutics market include Galderma S.A., Valeant Pharmaceuticals International Inc., Novartis AG, Pfizer Inc., Janssen Pharmaceuticals, and others. Leading companies in this market collaborate with healthcare solutions and services providers in order to advance operational efficiencies and provide improved patient care. Persistence Market Research (PMR) delivers key insights on the global dermatophytic onychomycosis therapeutics Market in its latest report titled “Global Market Study on Dermatophytic
Dermatophytic Onychomycosis Market : Topical segment to account 70% share
The global dermatophytic onychomycosis therapeutics market is anticipated to expand at a healthy CAGR during the forecast period. By product type, the market is segmented into Nail paint and tablet, which is again sub-divided into prescription (Rx) and over-the-counter (OTC) sub segments. The nail paint segment is expected to contribute a maximum share to the global dermatophytic onychomycosis therapeutics market and expand at the fastest CAGR of 8.3% during the